当前地点:

EN

选择地点:

Press Releases

More

2024/12/16

SINOVAC Initiated a Phase Ⅲ Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)

The first phase III clinical trial on a multivalent HFMD vaccine in the worldDecember 13, 2024, Beijing, China – Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a

Updates and Statements

More